Publication: Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort.
No Thumbnail Available
Identifiers
Date
2017-12-11
Authors
Fortner, Renée T
Schock, Helena
Le Cornet, Charlotte
Hüsing, Anika
Vitonis, Allison F
Johnson, Theron S
Fichorova, Raina N
Fashemi, Titilayo
Yamamoto, Hidemi S
Tjønneland, Anne
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
CA125 is the best ovarian cancer early detection marker to date; however, sensitivity is limited and complementary markers are required to improve discrimination between ovarian cancer cases and non-cases. Anti-CA125 autoantibodies are observed in circulation. Our objective was to evaluate whether these antibodies (1) can serve as early detection markers, providing evidence of an immune response to a developing tumor, and (2) modify the discriminatory capacity of CA125 by either masking CA125 levels (resulting in lower discrimination) or acting synergistically to improve discrimination between cases and non-cases. We investigated these objectives using a nested case-control study within the European Prospective Investigation into Cancer and Nutrition cohort (EPIC) including 250 cases diagnosed within 4 years of blood collection and up to four matched controls. Circulating CA125 antigen and antibody levels were quantified using an electrochemiluminescence assay. Adjusted areas under the curve (aAUCs) by 2-year lag-time intervals were calculated using conditional logistic regression calibrated toward the absolute risk estimates from a pre-existing epidemiological risk model as an offset-variable. Anti-CA125 levels alone did not discriminate cases from controls. For cases diagnosed
Description
MeSH Terms
Adult
Aged
Area Under Curve
Autoantibodies
Biomarkers, Tumor
CA-125 Antigen
Case-Control Studies
Cohort Studies
Early Detection of Cancer
Female
Humans
Membrane Proteins
Middle Aged
Ovarian Neoplasms
ROC Curve
Sensitivity and Specificity
Aged
Area Under Curve
Autoantibodies
Biomarkers, Tumor
CA-125 Antigen
Case-Control Studies
Cohort Studies
Early Detection of Cancer
Female
Humans
Membrane Proteins
Middle Aged
Ovarian Neoplasms
ROC Curve
Sensitivity and Specificity
DeCS Terms
CIE Terms
Keywords
CA125, MUC16, anti-CA125 antibodies, autoantibodies, early detection markers, ovarian cancer